
|Videos|September 13, 2016
Canine lymphoma update
Author(s)Sue Ettinger, DVM, DACVIM (oncology)
You may have heard it's coming, and now it's here: monoclonal antibody therapy to assist in the treatment of lymphoma in your canine veterinary patients.
Advertisement
Cancer. One word guaranteed to sober any veterinary exam room. But a new weapon of mass destruction just aimed its sights on one of the most common forms of canine cancer, lymphoma, as veterinary oncologist Dr. Sue Ettinger told us at CVC Virginia Beach in May. Used in conjunction with chemotherapy, monoclonal antibody therapy (e.g. Blontress-Aratana) flags cancer cells so the dog's immune system can attack them. Hear more:
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on dvm360
1
Interview with Dr Marty Goldstein
2
Every 30 extra minutes under anesthesia raises complication risk in brachycephalic patients, underscoring the importance of peri-anesthetic management
3
From the CVO: I’m off the clock
4
Paws and profits: VetEvolve names first chief veterinary officer, NVA appoints two board members, and more updates
5







